Telemedicine for Patients With Systemic Lupus Erythematosus in a Publicly Funded Hospital System: Retrospective Study
2024

Telemedicine for Patients With Systemic Lupus Erythematosus

Sample size: 156 publication Evidence: moderate

Author Information

Author(s): de Azevedo Cardoso Taiane, Patlolla Sridhar Reddy, Bruera Sebastian MD, Staggers Kristen Andrews MS, Suarez-Almazor Maria Eugenia MD, PhD, Agarwal Sandeep Krishna MD, PhD

Primary Institution: Baylor College of Medicine

Hypothesis

Patients with SLE in this system will have lower no-show rates with telemedicine modalities compared to in-person visits.

Conclusion

Telemedicine visits had decreased odds of no-shows without difference in laboratory testing adherence after adjustment for covariates.

Supporting Evidence

  • In 2020, the no-show rate for telemedicine was 5.5% compared to 16.2% for in-person visits.
  • After multivariable adjustment, the odds of no-show were lower for telemedicine visits.
  • Most patients were female and had a median age of 43 years.

Takeaway

Using telemedicine for lupus check-ups means fewer missed appointments, which is good for patients who might have trouble getting to the doctor.

Methodology

Retrospective cohort study comparing no-show rates for telemedicine and in-person visits.

Potential Biases

Potential bias due to the predominance of telephone encounters and lack of control for insurance type.

Limitations

The study did not adjust for disease severity and had a predominance of telephone encounters over video visits.

Participant Demographics

Most participants were female (90.4%), Hispanic (49.3%), with a median age of 43 years.

Statistical Information

P-Value

0.002

Confidence Interval

0.20-0.77

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.2196/49065

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication